MiniMed Group Stock (NASDAQ:MMED)

Revenue Financials Chart

Previous Close

$15.05

52W Range

$10.65 - $20.48

50D Avg

$13.23

200D Avg

$14.03

Market Cap

$4.29B

Avg Vol (3M)

$929.18K

Beta

-3.63

Div Yield

-

MMED Company Profile

MiniMed Group, Inc. specializes in designing, producing, and distributing a broad spectrum of medical technologies and solutions aimed at effective diabetes management. The company's diverse portfolio features essential tools like insulin pumps, continuous glucose monitoring (CGM) systems, infusion sets, specialized software platforms, and various supplementary accessories. These innovations are crafted to enable both patients and healthcare providers to accurately monitor and precisely regulate blood glucose levels. The enterprise was established in 1983 by Alfred E. Mann and is currently headquartered in Northridge, California.

Industry

Medical - Equipment & Services

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

-

IPO Date

Mar 05, 2026

Website

MMED Performance

MMED Financial Summary

	Apr 26	Apr 25	Apr 24
Revenue	$3.10B	$2.71B	$2.47B
Operating Income	$49.00M	$-202.00M	$-69.00M
Net Income	$-331.00M	$-250.00M	$-112.00M
EBITDA	$49.00M	$107.00M	$59.00M
Basic EPS	$-1.29	$-0.89	$-0.40
Diluted EPS	$-1.29	$-0.89	$-0.40

Fiscal year ends in Apr 26 | Currency in USD